Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
— Robust efficacy and evidence of a dose response from single intravitreal injection (IVT) of ADVM-022 —— Long-term durability beyond […]